Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Goodwill

As of the most recent data (March 2026), BLACR shows a goodwill of $30M. That compares with $24M in the prior-year period — up 21.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLACR's goodwill is now $30M (was $24M) — a 21.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is outperforming or lagging.

Tracking BLACR's goodwill over time shows whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is scaling, shrinking, or reshaping that part of the business. The current reading is $30M That compares with $24M in the prior-year period — up 21.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $30M) with ownership activity and broader fundamentals.